Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.125    -0.025 (-2.17%)
Bid:
1.05
Ask:
1.20
Spread: 0.15 (14.286%)
Market Cap: £9.62m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Form 8 (OPD) (Tern plc)

14 Jun 2022 07:00

RNS Number : 7206O
Tern PLC
14 June 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Tern plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

n/a

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Tern plc

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

13 June 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 0.02p each in Tern plc

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

 

Nil

 

(2) Cash-settled derivatives:

 

Nil

 

Nil

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

 

Nil

 

 

TOTAL:

Nil

 

Nil

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Ordinary shares of 0.02p each in Tern plc

Details, including nature of the rights concerned and relevant percentages:

Nil

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

Beneficial holdings of the Directors of Tern plc (including their close relatives) in its ordinary shares of 0.02p each

 

NAME

Number of Ordinary shares held

% of voting share capital

Albert Sisto

10,416,666

2.95

Bruce Leith1

8,857,233

2.51

Ian Ritchie

1,010,333

0.28

Sarah Payne

100,000

0.02

Matthew Scherba1

716,666

0.20

Alan Howarth

0

0.00

TOTAL

21,100,898

5.99%

 

1 - Including shares beneficially owned by close relatives.

 

Beneficial holdings of the directors of Tern plc in rights to subscribe for shares in Tern plc

 

NAME

Number of share options held2

Exercise price

Expiry Date

Albert Sisto

2,500,000

8.5p

18 May 2027

Bruce Leith

2,500,000

8.5p

18 May 2027

Sarah Payne

2,500,000

8.5p

18 May 2027

Matthew Scherba

2,500,000

9.15p

1 December 2029

Alan Howarth

250,000

13p

22 February 2023

TOTAL

10,250,000

 

2 - All share options have vested.

 

Interests held by connected advisers of Tern plc

 

NAME

Number of Ordinary shares held

% of voting share capital

Allenby Capital Limited

123,000

0.03%

TOTAL

123,000

0.03%

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

14 June 2022

Contact name:

Sarah Payne

Telephone number:

+44 (0) 203 807 0222

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEUOUWRUUUNAAR
Date   Source Headline
13th Aug 20187:01 amEQSTern PLC: Change of Adviser
10th Aug 20182:00 pmRNSPrice Monitoring Extension
8th Aug 20183:10 pmEQSTern PLC: Updated Director Information
8th Aug 20187:00 amEQSTern PLC: Director/PDMR Dealing
7th Aug 20184:40 pmRNSSecond Price Monitoring Extn
7th Aug 20184:35 pmRNSPrice Monitoring Extension
7th Aug 20188:00 amEQSTern PLC: DA Recognised as 2018 Emerging Star in IoT Security Market
3rd Aug 20184:41 pmRNSSecond Price Monitoring Extn
3rd Aug 20184:35 pmRNSPrice Monitoring Extension
3rd Aug 20187:00 amEQSTern PLC: Statement re: Device Authority Forecasts from September 2017
25th Jul 201811:05 amRNSSecond Price Monitoring Extn
25th Jul 201811:00 amRNSPrice Monitoring Extension
25th Jul 20188:40 amEQSTern PLC: InVMA Acquires Assets from AMIHO Technology
25th Jul 20187:00 amEQSTern PLC: Equity Fundraise of c. £2.9m
11th Jul 20188:00 amEQSTern PLC: Thales and Device Authority officially launch solution to secure the Connected Health industry
10th Jul 20187:00 amEQSTern PLC: Additional Investment in InVMA
3rd Jul 20184:40 pmRNSSecond Price Monitoring Extn
3rd Jul 20184:35 pmRNSPrice Monitoring Extension
25th Jun 20189:00 amEQSTern PLC: InVMA Announces Contract with ESAB
22nd Jun 20189:05 amRNSSecond Price Monitoring Extn
22nd Jun 20189:00 amRNSPrice Monitoring Extension
22nd Jun 20187:01 amEQSTern PLC: DA Security Blueprint
18th Jun 20187:00 amEQSTern PLC: Issue of Equity
14th Jun 20184:40 pmRNSSecond Price Monitoring Extn
14th Jun 20184:35 pmRNSPrice Monitoring Extension
14th Jun 20189:00 amRNSPrice Monitoring Extension
13th Jun 20184:40 pmRNSSecond Price Monitoring Extn
13th Jun 20184:35 pmRNSPrice Monitoring Extension
13th Jun 20182:06 pmRNSSecond Price Monitoring Extn
13th Jun 20182:00 pmRNSPrice Monitoring Extension
13th Jun 201812:46 pmEQSTern PLC: Statement re: Share Price Movement
13th Jun 201811:05 amRNSSecond Price Monitoring Extn
13th Jun 201811:00 amRNSPrice Monitoring Extension
12th Jun 201811:00 amRNSPrice Monitoring Extension
12th Jun 20187:00 amEQSTern PLC: DA Launches KeyScaler SaaS
11th Jun 20189:06 amRNSSecond Price Monitoring Extn
11th Jun 20189:00 amRNSPrice Monitoring Extension
11th Jun 20187:00 amEQSTern PLC: Issue of Loan to Device Authority
8th Jun 201810:15 amEQSTern PLC: Statement re: Share Price Movement
30th May 20189:03 amEQSTern PLC: Holdings in Company
22nd May 20187:00 amEQSTern PLC: DA Strategic Partnerships with SyroCon Consulting and EonTi
16th May 20187:00 amEQSTern PLC: Portfolio Update
14th May 20187:00 amEQSTern PLC: Raises £700,000 and Acquires Stake in Medical VR Company
8th May 20187:01 amEQSTern PLC: Equity Fundraise
3rd May 20187:00 amEQSTern PLC: GCE Healthcare Launches Platform Developed by InVMA to Market
30th Apr 20189:05 amEQSTern PLC: Update following the Shareholder Conference Call
25th Apr 20187:06 amEQSTern PLC: Additional Investment in InVMA
24th Apr 20184:41 pmRNSSecond Price Monitoring Extn
24th Apr 20184:35 pmRNSPrice Monitoring Extension
24th Apr 20183:25 pmEQSTern PLC: Result of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.